TrialsgrambetaRCTs are beautiful

POISE-2

2014

PeriOperative ISchemic Evaluation-2 trial

In 10,010 patients at risk of vascular complications undergoing non-cardiac surgery, neither low-dose aspirin nor clonidine started just before surgery reduced death or non-fatal myocardial infarction at 30 days; aspirin increased major bleeding and clonidine increased hypotension, compared with placebo.

Result

Primary endpoint: Composite of death or non-fatal myocardial infarction at 30 days

Aspirin 7.0 % vs 7.1 % (HR 0.99; p=0.92) with major bleeding 4.6 % vs 3.8 % (HR 1.23; p=0.04). Clonidine HR 1.08 (p=0.29) with clinically important hypotension 47.6 % vs 37.1 % (p<0.001).

Original publication
Subtopic
Aspirin and clonidine
Design
2×2 factorial, double-blind, placebo-controlled RCT
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Devereaux PJ, Mrkobrada M, Sessler DI, et al. N Engl J Med. 2014;370(16):1494-1503.doi 10.1056/NEJMoa1401105

Discussion & critique

Patients with recent coronary stents were excluded, so it cannot be extrapolated to dual antiplatelet therapy after recent PCI. Within its population it is decisive: it removed the rationale for routinely starting perioperative aspirin or clonidine.